sertraline

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf antidepressant
selective serotonin reuptake inhibitor
gptkbp:approvalYear 1991
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode gptkb:N06AB06
gptkbp:availableGeneric yes
gptkbp:availableOn gptkb:tablet
oral concentrate
gptkbp:brand gptkb:Lustral
gptkb:Zoloft
gptkbp:CASNumber gptkb:79617-96-2
gptkbp:chemicalFormula C17H17Cl2N
gptkbp:contraindication concurrent use with MAO inhibitors
gptkbp:developedBy gptkb:Pfizer
gptkbp:drugClass SSRI
gptkbp:eliminationHalfLife 26 hours
gptkbp:excretion gptkb:kidney
gptkbp:firstMarketedYear 1991
https://www.w3.org/2000/01/rdf-schema#label sertraline
gptkbp:interactsWith gptkb:warfarin
gptkb:MAO_inhibitors
gptkb:NSAIDs
gptkb:pimozide
other serotonergic drugs
antiplatelet drugs
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits reuptake of serotonin
gptkbp:metabolism liver
gptkbp:molecularWeight 306.23 g/mol
gptkbp:patentedYear 1978
gptkbp:pregnancyCategory C (US)
gptkbp:prescribes adults
children (OCD only)
gptkbp:riskOfDiscontinuationSyndrome yes
gptkbp:riskOfSerotoninSyndrome yes
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
diarrhea
dizziness
insomnia
drowsiness
dry mouth
sexual dysfunction
gptkbp:usedFor gptkb:obsessive-compulsive_disorder
gptkb:panic_disorder
gptkb:post-traumatic_stress_disorder
gptkb:social_anxiety_disorder
gptkb:major_depressive_disorder
premenstrual dysphoric disorder
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:CYP3A4
gptkb:Zoloft
gptkbp:bfsLayer 5